Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?

How to track cellular aging of mesenchymal stromal cells?

(2016) Wolfgang Wagner et al.   Aging-US

Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy

(2011) Lena von Bahr et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Crimean-Congo Hemorrhagic Fever Virus Activates Endothelial Cells

(2011) A.-M. Connolly-Andersen et al.   JOURNAL OF VIROLOGY

Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses

(2011) Guido Moll et al.   PLoS One

Therapeutic Applications of Mesenchymal Stromal Cells: Paracrine Effects and Potential Improvements

(2011) Joyce Doorn et al.   TISSUE ENGINEERING PART B-REVIEWS

The Instant Blood-Mediated Inflammatory Reaction Characterized in Hepatocyte Transplantation

(2011) Elisabet K. Gustafson et al.   TRANSPLANTATION

Pooled MSCs for treatment of severe hemorrhage

(2010) O Ringdén et al.   BONE MARROW TRANSPLANTATION

Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?

(2010) Ann H. Klopp et al.   STEM CELLS

Mesenchymal Stem Cells Inhibit Complement Activation by Secreting Factor H

(2010) Zhidan Tu et al.   STEM CELLS AND DEVELOPMENT

Mesenchymal stem cell therapy: Two steps forward, one step back

(2010) James Ankrum et al.   TRENDS IN MOLECULAR MEDICINE

Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces

(2009) Jennie Bäck et al.   BIOMATERIALS

Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6

(2009) Ryang Hwa Lee et al.   Cell Stem Cell

Mesenchymal Stem Cell Homing: The Devil Is in the Details

(2009) Jeffrey M. Karp et al.   Cell Stem Cell

C3a and C5a Are Chemotactic Factors for Human Mesenchymal Stem Cells, Which Cause Prolonged ERK1/2 Phosphorylation

(2009) I. U. Schraufstatter et al.   JOURNAL OF IMMUNOLOGY

Is the intravascular administration of mesenchymal stem cells safe?

(2009) Dario Furlani et al.   MICROVASCULAR RESEARCH

Repair of Tissues by Adult Stem/Progenitor Cells (MSCs): Controversies, Myths, and Changing Paradigms

(2009) Darwin J Prockop   MOLECULAR THERAPY

Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?

(2009) Bo Nilsson et al.   TRENDS IN IMMUNOLOGY

The CD34-like protein PODXL and  6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice

(2008) R. H. Lee et al.   BLOOD

A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs

(2008) Mihaela Crisan et al.   Cell Stem Cell

Fate Of Culture-Expanded Mesenchymal Stem Cells in The Microvasculature

(2008) Catalin Toma et al.   CIRCULATION RESEARCH

Activated platelets increase fibrinolysis of mesenchymal progenitor cells

(2008) Hermann Agis et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Why are MSCs therapeutic? New data: new insight

(2008) AI Caplan   JOURNAL OF PATHOLOGY

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

(2008) Katarina Le Blanc et al.   LANCET

Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production

(2008) Krisztián Németh et al.   NATURE MEDICINE

Multipotent Stromal Cells Are Activated to Reduce Apoptosis in Part by Upregulation and Secretion of Stanniocalcin-1

(2008) Gregory J. Block et al.   STEM CELLS

Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect

(2008) Uwe M. Fischer et al.   STEM CELLS AND DEVELOPMENT

Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies

(2007) A. Stolzing et al.   MECHANISMS OF AGEING AND DEVELOPMENT